the invention provides methods of preventing or treating muscular weakness in a patient with Parkinson's disease and/or of improving or restoring muscular strength of a patient with Parkinson's disease, by administering one or more hepatocyte growth factor mimics as described herein
Our clinician-led guide details how we monitor hydration and electrolytes to ensure a seamless and safe experience
Copyright 2025 Moon Integrated Health Clinic - All Rights Reserved
Ultimately, targeting GLP-1R signaling may represent a novel approach for asthma therapy that is glucocorticoid sparing and possibly disease modifying
These results are interpreted as a strong indication of injury or damage to heart tissue in the hyperthyroid state, consistent with prior investigations by Sridharan and Shyamaladevi 101 , Iqbal et al
175 Arginine-succinate synthetase 1 (ASS1) transcriptional repression occurs in various tumors, creating a dependence on external arginine and enabling arginine-deprivation therapy